GSK
InterMune stock jumps on suitor claims
August 14, 2014Sales and Marketing Boehringer, Esbriet, FDA, GSK, IPF, InterMune
Riding high of the success of its new lung drug Esbriet, InterMune has become the focus of some serious takeover …
GSK now faces bribery allegations in Syria
August 13, 2014Medical Communications, Sales and Marketing China, GSK, bribery
GlaxoSmithKline faces fresh allegations that it bribed Syrian doctors and officials to boost sales of its medicines in what is …
GSK Ebola vaccine underway
August 11, 2014Research and Development, Sales and Marketing Africa, Ebola, GSK, Vaccine, WHO, johnson
Clinical trials of an experimental vaccine against the deadly Ebola virus will begin soon according to its developers GlaxoSmithKline. The …
GSK investigator jailed by Chinese police
August 8, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Peter Humprhey
A private investigator hired by GlaxoSmithKline to look into the secret recording of a sex tape of its China boss …
RBS chairman favoured as next GSK head
August 8, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, RBS, Sir Christopher Gent
The Royal Bank of Scotland’s current head Sir Philip Hampton is the most likely candidate to take over as the …
GSK seeks regulatory review of first malaria vaccine
July 26, 2014Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, malaria, rts, s
GSK has submitted a regulatory application to the European Medicines Agency for its malaria vaccine candidate RTS,S and hopes it …
More action needed on antibiotic resistance
July 25, 2014Medical Communications, Research and Development, Sales and Marketing AMR, Antibiotics, AstraZeneca, GSK, HIV, MRC, WHO, walsh
Pharma and governments need to put their heads together urgently in order to tackle the threat of antimicrobial resistance (AMR), …
Another major drop in sales for GSK
July 23, 2014Sales and Marketing China, GSK, Q2, Witty, bribery, sales, scandal, sex
GlaxoSmithKline posted a 4% slide in revenue for the second quarter today as its recovery from a slew of patent …
GSK melanoma drugs beat rival in new study
July 18, 2014Sales and Marketing GSK, Roche, Tafinlar, Yervoy, Zelboraf, mekinist, melanoma
GlaxoSmithKline’s new combination melanoma treatment has bested Roche’s established oncology drug Zelboraf when treating patients with the deadliest form of …
Roche combination drug for melanoma impresses
July 14, 2014Research and Development, Sales and Marketing GSK, Roche, Yervoy, braf, mekinist. MEK, melanoma
Roche’s investigational melanoma drug cobimetinib has helped late-stage patients live longer when used in combination with its established skin cancer …
GSK investigator charged in China
July 14, 2014Medical Communications, Sales and Marketing China, GSK, Witty, bribery, humphrey, sex tape
The man who GlaxoSmithKline paid to investigate an illegally produced sex tape of one its senior employees has been charged …
GSK manufacturing woes continue
July 8, 2014Manufacturing and Production Canada, FDA, GSK, Paxil, Vaccine, manufacturing
Health Canada has told GlaxoSmithKline that it wants to see the firm fix major problems at the country’s only flu …
Mekinist shown EU green light
July 7, 2014Sales and Marketing CHMP, Cancer, GSK, Tafinlar, braf, mekinist, melanoma
The European Commission has given GlaxoSmithKline’s melanoma drug Mekinist the thumbs-up following a positive opinion in April from the European …
GSK China sex tape ‘sent to Witty’
June 30, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Mark Reilly, Witty, corruption, sex tape
GlaxoSmithKline was scrambling to defend itself over the weekend as new details emerged concerning the extent of its suspected corruption …
FDA warns GSK plant
June 26, 2014Manufacturing and Production, Sales and Marketing FDA, GSK, Quebec, flu, flulaval, vaccines
GlaxoSmithKline’s Canadian operation has incurred the displeasure of the US Food and Drug Administration for irregularities in its production of …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
